Royalty Pharma Announces that James Reddoch, Ph.D., Joins Management Team NEW YORK, July 8 /PRNewswire/ -- Royalty Pharma is pleased to announce that James Reddoch, Ph.D., has joined the company as Executive Vice President, Head of Research.Reddoch has 17 years of experience in the biotechnology sector.
He...
UCB: European submission for rheumatoid arthritis treatment UCB's new biologic is awaiting European approval after being launched in the US for Crohn's disease.UCB's certolizumab is marketed under the brand name Cimzia.The submission for rheumatoid arthritis treatment, if accepted, will make it...
Big haul of Crohn's genes shows disease complexity LONDON - Scientists have linked 32 genetic variations to Crohn's disease, a bowel disorder, highlighting the complexity of many common diseases and the difficulties facing researchers seeking treatments.Scientists said on Sunday that new...
Crohn's Disease Linked To More Genetic Variations Scientists revealed on Sunday new research the shows Crohns disease to be more complex than previously thought.Researchers found a total of 32 genetic variations that accounted for Crohns disease, thus almost tripling the number of...
Big haul of Crohn's genes shows disease complexity LONDON (Reuters) - Scientists have linked 32 genetic variations to Crohn's disease, a bowel disorder, highlighting the complexity of many common diseases and the difficulties facing researchers seeking treatments.Scientists said on Sunday...
20 Compounds That Defined Biotech As we know all too well, the course of a drug candidates clinical development is almost never smooth, and can often be pitted with unanticipated obstacles.Yet, despite this, many drugs manage to not only receive the FDAs blessing, but...
Kids Fighting Crohn's LAS VEGAS, Nev.(Ivanhoe Newswire) -- More than half a million Americans are living with Crohn's disease and more than 100,000 of them are kids.
There's no cure, but researchers have found a way to help ease the painful symptoms.
Examine the Monoclonal Antibodies Report: 2008 Update Examine the Monoclonal Antibodies Report: 2008 Update - Detailed analysis of the monoclonal antibody segment, encompassing market dynamics, key therapy areas, technology and target types through to 2013, evaluating the strategies companies...
Examine the Monoclonal Antibodies Report: 2008 Update The report provides a comprehensive financial and strategic analysis of the mAb market, forecasting its commercial evolution out to 2013 and assessing trends by product, company, therapy area, technology and target type.It also provides...
UK health watchdog recommends Abbott's Humira for psoriasis if other drugs fail LONDON (Thomson Financial) - The UK's healthcare spending watchdog, the National Institute for Health and Clinical Excellence (NICE), has recommended the use of Abbott Laboratories' psoriasis treatment Humira only if the condition is...
UK health watchdog recommends Abbott's Humira for psoriasis if other drugs fail LONDON (Thomson Financial) - The UK's healthcare spending watchdog, the National Institute for Health and Clinical Excellence (NICE), has recommended the use of Abbott Laboratories' psoriasis treatment Humira only if the condition is...
Abbott Japan aiming for pharma sales of $1B within two years, boosted by Humira US health care major Abbott Laboratories sees a strong future on the Japanese market.'We are aiming at pharmaceutical sales of $1.0 billion or 100.0 billion yen within two years from now on because the company will grow by 7% to 9%...
UK health watchdog recommends Abbott's Humira for psoriasis if other drugs fail LONDON (Thomson Financial) - The UK's healthcare spending watchdog, the National Institute for Health and Clinical Excellence (NICE), has recommended the use of Abbott Laboratories' psoriasis treatment Humira only if the condition is...
UK health watchdog recommends Abbott's Humira for psoriasis if other drugs fail LONDON (Thomson Financial) - The UK's healthcare spending watchdog, the National Institute for Health and Clinical Excellence (NICE), has recommended the use of Abbott Laboratories' psoriasis treatment Humira only if the condition is...
Humira recommended for plaque psoriasis _ Humira recommended for plaque psoriasis.
NICE approves new anti-obesity drug NICE has issued final guidance approving the use of a new anti-obesity drug on the NHS.A health technology appraisal, published this week, recommends that rimonabant (Acomplia) should only be used as an addition to diet and exercise for...
NICE Recommends Abbott's Adalimumab (HUMIRA(R)) for the Treatment of Chronic Plaque Psoriasis MAIDENHEAD, England, June 25 /PRNewswire/ -- - For the Attention of UK Publications Only The National Institute for Health and Clinical Excellence (NICE) today recommended adalimumab (HUMIRA) as a treatment option for adults with...
Psoriasis Drug Will be Approved Despite Cancer Concerns An experimental Johnson & Johnson drug should be approved for treating adults with moderate or severe psoriasis, the Food and Drug Administration advisory panel unanimously ruled.The ability of the drug, ustekinumab, to relieve...
Live From Bio: Personalized Medicine Fool contributor and health-care sector editor Brian Orelli hung out at the Bio International Convention this week.This concludes his series on the hot topics at the conference that will affect the industry and the stocks you invest in.
Live From Bio: Personalized Medicine Fool contributor and health-care sector editor Brian Orelli hung out at the Bio International Convention this week.This concludes his series on the hot topics at the conference that will affect the industry and the stocks you invest in.
FDA Panel Favors Approval For Amgen's Enbrel To Treat Kids With Severe Skin Disease (FinancialWire) A panel of dermatology experts for the Food and Drug Administration said Amgen Inc.'s (NASDAQ: AMGN) drug Enbrel should be approved to treat children with a serious skin disease.Earlier this month, the FDA said that it was...
FDA Panel Favors Approval For Amgens Enbrel To Treat Kids With Severe Skin Disease (FinancialWire) A panel of dermatology experts for the Food and Drug Administration said Amgen Inc.'s (NASDAQ: AMGN) drug Enbrel should be approved to treat children with a serious skin disease.Earlier this month, the FDA said that it was...
CEL-SCI announces discovery of new arthritis drug The tests showed that CEL-2000 is equivalent or possibly superior to Enbrel in slowing disease progression and lessening symptoms in mice.In addition, the vaccine has the potential to require fewer and smaller doses, be less toxic, more...
Zacks Releases Four Powerful ''Buy'' Stocks: Compass Minerals International, Abbott Laboratories, Patriot Coal - Four free stock picks are being made available today on Zacks.com.The industry's leading independent research firm highlights one Zacks #1 Rank Strong Buy or a Zacks #2 Rank Buy stock for each of the four main styles of investing:...
HUMIRA Subcutaneous Injection 40mg Syringe 0.8mL Now Available for the Treatment of Rheumatoid Arthritis Abbott Japan Co., Ltd.(Pharmaceutical Products Group in Tokyo, President: Glenn S.
Warner) and Eisai Co., Ltd.
(Headquarters in Tokyo, President and CEO: Haruo Naito) announced that HUMIRA subcutaneous injection 40mg Syringe 0...
